Key Finding
Electroacupuncture combined with escitalopram significantly increased BDNF and glucocorticoid-inducible genes while decreasing IL-6, with IL-6 reduction positively correlating with depression symptom improvement.
Researchers investigated whether electroacupuncture (EA) could enhance the effects of escitalopram, a common antidepressant medication, for people with mild-to-moderate depression. The study included 61 participants who were randomly assigned to receive either electroacupuncture alone, escitalopram alone, or a combination of both treatments for six weeks.
All three treatment groups showed improvements in depression symptoms and quality of life. However, the combination treatment group experienced significantly greater improvements in anxiety symptoms, both psychological and physical, compared to either treatment alone.
What makes this study particularly interesting is that researchers measured biological markers in the blood to understand how electroacupuncture works. They found that patients receiving combined electroacupuncture and medication showed significant positive changes in several important biological markers: increased levels of BDNF (a protein that supports brain health), increased expression of genes that help the body respond to stress (SGK1 and GILZ), and decreased levels of IL-6 (an inflammatory marker associated with depression).
The reduction in inflammation (IL-6) was directly correlated with improvement in depression scores, suggesting that electroacupuncture may help treat depression partly by reducing inflammation in the body. These findings suggest that electroacupuncture combined with antidepressant medication may be more effective than either treatment alone, working through multiple biological pathways including reducing inflammation, supporting brain health, and improving stress response.
If you're considering electroacupuncture for depression, consult with a licensed acupuncturist who has experience treating mental health conditions.
This single-blind, double-dummy RCT enrolled 61 patients with mild-to-moderate depression (ICD-10 F32) randomized to electroacupuncture plus escitalopram oxalate placebo, escitalopram oxalate plus sham EA, or combined EA and escitalopram oxalate for six weeks. While all three interventions improved depression severity and quality of life with no significant inter-group differences at week 6, the combination group demonstrated superior improvements in anxiety psychic and somatic symptoms (P<0.05). Biological markers revealed that combined treatment significantly increased SGK1 mRNA, GILZ mRNA, and BDNF levels while decreasing IL-6 levels (P<0.05). Notably, IL-6 reduction positively correlated with HAMD-24 score improvement. Clinical takeaway: Electroacupuncture as adjunct therapy to escitalopram appears to enhance antidepressant efficacy through multi-targeted mechanisms involving neurotrophin upregulation, anti-inflammatory effects, and modulation of glucocorticoid-inducible genes, particularly benefiting anxiety symptoms in depression. The correlation between IL-6 reduction and symptomatic improvement suggests inflammation as a key mechanistic pathway.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Acupuncture combined with wet cupping therapy produced significantly greater improvements in depression scores and neurological function in post-stroke depression patients compared to acupuncture alone, accompanied by favorable changes in stress hormones and inflammatory markers.
📌 Menopausal women experience depression rates 2-3 times higher than premenopausal women due to estrogen fluctuations that disrupt neurotransmitter systems, HPA axis function, and trigger neuroinflammation.
📌 Nine percent of perinatal women experience persistent depression throughout pregnancy and postpartum, with distinct risk factors predicting different depressive symptom trajectories requiring individualized treatment approaches.